Cargando…

Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)

Epithelial-mesenchymal transition (EMT) is able to drive metastasis during progression of multiple cancer types, including non-small cell lung cancer (NSCLC). As resistance to immunotherapy has been associated with EMT and immune exclusion in melanoma, it is important to understand alterations to T-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chae, Young Kwang, Chang, Sangmin, Ko, Taeyeong, Anker, Jonathan, Agte, Sarita, Iams, Wade, Choi, Wooyoung M., Lee, Kyoungmin, Cruz, Marcelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811447/ https://www.ncbi.nlm.nih.gov/pubmed/29440769 http://dx.doi.org/10.1038/s41598-018-21061-1

Ejemplares similares

Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer
por: Chae, Young Kwang, et al.
Publicado: (2018)

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
por: Chae, Young Kwang, et al.
Publicado: (2018)

Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy
por: Chae, Young Kwang, et al.
Publicado: (2020)

Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma
por: Chae, Young Kwang, et al.
Publicado: (2019)

Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast
por: Iams, Wade T., et al.
Publicado: (2023)

Successful Treatment and Retreatment With Erdafitinib for a Patient With FGFR3-TACC3 Fusion Squamous NSCLC: A Case Report
por: Pham, Chi, et al.
Publicado: (2023)

Two Uncomplicated Pregnancies on Alectinib in a Woman With Metastatic ALK-Rearranged NSCLC: A Case Report
por: Weidenbaum, Chloe, et al.
Publicado: (2022)

Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs
por: Farhan, Mohd, et al.
Publicado: (2019)

miR-151a induces partial EMT by regulating E-cadherin in NSCLC cells
por: Daugaard, I, et al.
Publicado: (2017)

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021)

Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer
por: Wong, Selina K., et al.
Publicado: (2021)

Mutations in DNA repair genes are associated with increased neo-antigen load and activated T cell infiltration in lung adenocarcinoma
por: Chae, Young Kwang, et al.
Publicado: (2017)

EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
por: Zhu, Xuan, et al.
Publicado: (2019)

Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity
por: Feng, Jian, et al.
Publicado: (2014)

TMEM107 inhibits EMT and invasion of NSCLC through regulating the Hedgehog pathway
por: Xu, Huihui, et al.
Publicado: (2020)

Alectinib and lorlatinib function by modulating EMT-related proteins and MMPs in NSCLC metastasis
por: Feng, Xu, et al.
Publicado: (2021)

UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT
por: Zhang, Jiguang, et al.
Publicado: (2022)

PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC
por: Racherla, Kavya Sri, et al.
Publicado: (2023)

Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
por: Ahmad, Aamir, et al.
Publicado: (2013)

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021)

Use of Cabozantinib in a Patient With EGFR-Mutated Non–Small-Cell Lung Cancer Harboring Acquired CCDC6-RET Fusion
por: Chae, Young Kwang, et al.
Publicado: (2019)

EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms
por: Venugopal, Abhirami, et al.
Publicado: (2022)

Knocking down MiR-15a expression promotes the occurrence and development and induces the EMT of NSCLC cells in vitro
por: He, Jia
Publicado: (2017)

Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549()
por: Tièche, Colin Charles, et al.
Publicado: (2018)

MiR-22-3p suppresses NSCLC cell migration and EMT via targeting RAC1 expression
por: Wang, Xuejiao, et al.
Publicado: (2023)

Enhanced nuclear localization of YAP1‐2 contributes to EGF‐induced EMT in NSCLC
por: Guo, Qiang, et al.
Publicado: (2022)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

Comparison of fluorescence intensity of Hoechst 33342-stained EMT6 tumour cells and tumour-infiltrating host cells.
por: Loeffler, D. A., et al.
Publicado: (1987)

Signatures of human impact on self-organized vegetation in the Horn of Africa
por: Gowda, Karna, et al.
Publicado: (2018)

Carcinoid tumors outside the abdomen
por: Koehler, Kenna, et al.
Publicado: (2022)

Study on Attenuating Angiogenesis and Epithelial–Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2
por: Jiang, Sicong, et al.
Publicado: (2018)

Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer
por: Huang, Xiaowei, et al.
Publicado: (2021)

Inversion-based genomic signatures
por: Swenson, Krister M, et al.
Publicado: (2009)

Achyranthes bidentata polysaccharide can safely prevent NSCLC metastasis via targeting EGFR and EMT
por: Zhong, Chunlian, et al.
Publicado: (2020)

FOXM1 Regulated by ERK Pathway MediatesTGF-β1-Induced EMT in NSCLC
por: Kong, Fei-Fei, et al.
Publicado: (2014)

EMT is associated with an epigenetic signature of ECM remodeling genes
por: Peixoto, Paul, et al.
Publicado: (2019)

Prognostic Value of EMT Gene Signature in Malignant Mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures
por: Peindl, Matthias, et al.
Publicado: (2022)

An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC
por: Yu, Hongliang, et al.
Publicado: (2021)

Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature
por: Basu, Arkaprabha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t3j3t3p8mhipptdmkab3tdui7b